WEVEE vaccine shows promise against trio of rare but deadly viruses

Phase I trial data suggests that a vaccine targeting three mosquito-borne encephalitis viruses is safe and can elicit an immune response.

Related Keywords

United States ,Venezuela ,Venezuelan ,America , ,Vaccine Research Center ,Us National Institute Of Allergy ,Emory Vaccine Center Hope Clinic ,Emory University In Atlanta ,Program Executive Office Chemical ,Nuclear Defense ,Us Department Of Defense ,Us National Institutes Of Health ,South America ,Infectious Diseases ,Research Center ,Emory Vaccine Center ,Hope Clinic ,Emory University ,Interagency Agreement ,Joint Program Executive Office Chemical ,Lancet Infectious ,